http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004047814-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed7633802eb1602e05094a336f2ba03b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e8581406db484b1f3e921377dbb01a89 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fc6c2e9e63b6561f2f46b1de31f6379 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6eb4a3dd62f830188ab3f68cee3f8fba http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be5bb33575c972a0487ee9dce26e55aa |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7069 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42 |
filingDate | 2003-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fc7786c3111ba780d8d8e1717cc127c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96dab1000c70845d2e52536e087368b1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c1cc33ea1c01a7b9c70ade98ddc022d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55b7567d83d4e1bd48bcfc492db0f5e1 |
publicationDate | 2004-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2004047814-A1 |
titleOfInvention | Dermal delivery of a water-soluble selective cyclooxygenase-2 inhibitor, e.g. parecoxib, valdecoxib and benzopyran derivatives |
abstract | A pharmaceutical composition for application to an area of skin of a subject for local and/or systemic treatment of a COX-2 mediated disorder comprises a backing sheet that is flexibly conformable to the area of skin, the backing sheet having opposing surfaces that are respectively distal and proximal to the skin when applied; and a coating on the proximal surface of the backing sheet that comprises (a) an adhesive and (b) a water-soluble active agent selected from selective COX-2 inhibitory drugs, prodrugs and salts thereof, the active agent being in a therapeutically effective total amount and dispersed in a matrix that comprises zero to less than an active agent solubilizing effective amount in total of one or more solvents other than the adhesive. A method of local treatment of a site of pain and/or inflammation in a subject comprises applying the composition to a skin surface of the subject, preferably at a locus overlying or adjacent to the site of pain and/or inflammation, and leaving the composition in place for a time period effective to permit delivery of a locally therapeutic amount of the active agent. A method of systemic treatment of a subject having a COX-2 mediated disorder comprises applying the composition to a skin surface of the subject, and leaving the composition in place for a time period effective to permit transdermal delivery of a therapeutic amount of the active agent. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009512645-A |
priorityDate | 2002-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1835.